Disclosure 0001193125-26-355735-1

SEC FORM 4

$528,400.00

Viridian Therapeutics, Inc.\DE (VRDN)

Acquisition (code M) of 40,000 shares at $13.21 per share.

Reporting Person Tripuraneni Radhika · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355735 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Viridian Therapeutics, Inc.\DE (VRDN)." Disclosed 2026-08-18. https://desqlong.com/cards/0001193125-26-355735-1 (retrieved 2026-09-26).